Wixela vs Flovent
What to choose Wixela or Flovent
Wixela is inhaler of type Control while Flovent is of Control type. Wixela and Flovent are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Flovent is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Flovent is Fluticasone. The available dosages for Flovent are 44 mcg, 110 mcg, 220 mcg.
The actual price for Wixela is approximately $240 while average cost for Flovent is approximately $198, said Soren Myers, a Research Associate at the West Texas A&M University and a Physician at a clinic that uses Wixela and Flovent.
Wixela and Flovent Comparison
| Wixela | Flovent | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Viatris | GSK |
| Substance: | Fluticasone + Salmeterol | Fluticasone |
| Dosage: | 250/50 | 44 mcg, 110 mcg, 220 mcg |
| Avg Price: | $240 | $198 |